Jeff Lindquist
About Jeff Lindquist
Jeff Lindquist is a Principal R&D Engineer at Boston Scientific, known for developing medical devices and holding over 20 patents.
Company
Jeff Lindquist is currently employed at Boston Scientific in Maple Grove, MN. He has been with the company since 2000, contributing his expertise to the development of various medical devices. Under his role as Principal R&D Engineer, Boston Scientific benefits from his extensive experience and innovative approach to medical technology.
Title
Jeff Lindquist holds the position of Principal R&D Engineer at Boston Scientific. His role involves leading research and development initiatives to innovate and improve medical device technologies. His responsibilities include overseeing the development of various products and ensuring they meet industry standards.
Education and Expertise
Jeff Lindquist studied Chemistry at the University of Wisconsin, where he earned his BS degree from 1983 to 1988. His expertise lies in the research and development of medical devices, including IC and PI balloon catheters, lubricious coatings, drug coatings, and devices for hypertension and interventional oncology. His educational background in chemistry has been fundamental in his career as a research chemist and R&D engineer.
Professional Background
Before joining Boston Scientific, Jeff Lindquist worked as a Research Chemist at HB Fuller in Vadnais Heights, MN, from 1988 to 2000. Prior to that, he was a Lab Technician at 3M in St. Paul, MN, from 1984 to 1988. Throughout his career, he has gained extensive experience in chemical research and medical device development, which has been pivotal in his success at Boston Scientific.
Achievements
Jeff Lindquist holds over 20 patents related to medical devices. In recognition of his significant contributions to medical device product development, he received the 2018 Abele Technology Award at Boston Scientific. His work includes the development of IC and PI balloon catheters, lubricious coatings, drug coatings, and devices for hypertension and interventional oncology.